The invention presents an innovative method that leverages ultrasound (US) technology to deliver doxorubicin (Dox) via a microbubble-liposome complex (DoxLPX) for cancer treatment.
Yu, F. T. H., Chen, X., Wang, J., Qin, B., & Villanueva, F. S. (2015). Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles. Molecular Pharmaceutics, 13(1), 55–64. https://doi.org/10.1021/acs.molpharmaceut.5b00421